15
Participants
Start Date
April 6, 2022
Primary Completion Date
October 31, 2026
Study Completion Date
March 31, 2028
Transcatheter Tricuspid Valved Stent Graft
All participants meeting the inclusion and none of the exclusion criteria will be enrolled. A custom-made Transcatheter Tricuspid Valved Stent Graft based on CT to define anatomic dimensions will be made. The system consists of a custom-made valved stent graft delivery system, a custom-made valved stent graft bioprosthesis and a loading system. The bioprosthesis is self-expanding and consists of a stent graft spanning from the inferior vena cava to the superior vena cava and a lateral bicuspid valve element made of thin porcine pericardial leaflets requiring a low closing pressure, and Nitinol support structures. The participants will undergo a minimally invasive, catheter-based procedure to implant the bioprosthesis which is delivered through a 24 French delivery system via transfemoral access. The device can be repositioned and is retrievable.
Barts Health NHS Trust, London
Royal Free Hospital NHS Foundation Trust
OTHER
Queen Mary University of London
OTHER